You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Antiangiogenesis

Showing 26 - 50 of 110
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Refractory or Recurrent Solid Tumors, Acute Myelogenous Leukemia Trial in Philadelphia (Cediranib, AZD2171, RECENTIN)

Completed
  • Refractory or Recurrent Solid Tumors
  • Acute Myelogenous Leukemia
  • Cediranib, AZD2171, RECENTIN
  • Philadelphia, Pennsylvania
    Childrens Hospital, Philadelphia
Nov 20, 2019

Kaposi's Sarcoma, HHV-8, KSHV Trial run by the NCI (BAY 43-9006)

Terminated
  • Kaposi's Sarcoma
  • +2 more
  • BAY 43-9006
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 11, 2019

Nasopharyngeal Tumors Trial (endostar, intensity modulated radiation, cisplatin)

Completed
  • Nasopharyngeal Neoplasms
  • (no location specified)
Jun 22, 2020

Hepatocellular Carcinoma Trial in Magdeburg (RFA, Radioembolization (SIRT))

Completed
  • Hepatocellular Carcinoma
  • RFA
  • Radioembolization (SIRT)
  • Magdeburg, Germany
    University of Magdeburg
May 29, 2019

Adenocarcinoma of the Prostate, Recurrent Prostate Cancer, Stage I Prostate Cancer Trial in Detroit (bevacizumab, laboratory

Completed
Has Results
  • Adenocarcinoma of the Prostate
  • +5 more
  • bevacizumab
  • laboratory biomarker analysis
  • Detroit, Michigan
  • +1 more
Jul 1, 2018

Recurrent Mantle Cell Lymphoma Trial in United States (Bortezomib, Laboratory Biomarker Analysis, Lenalidomide)

Completed
Has Results
  • Recurrent Mantle Cell Lymphoma
  • Anaheim, California
  • +81 more
Oct 2, 2018

Bone Cancer, Chondrosarcoma, Clear Cell Sarcoma of the Kidney Trial in Winston-Salem (therapeutic angiotensin-(1-7), laboratory

Completed
Has Results
  • Bone Cancer
  • +11 more
  • therapeutic angiotensin-(1-7)
  • laboratory biomarker analysis
  • Winston-Salem, North Carolina
    Wake Forest University Health Sciences
Jul 2, 2018

Adenocarcinoma of the Lung, Adenosquamous Cell Lung Cancer, Bronchoalveolar Cell Lung Cancer Trial in Winston-Salem (drug,

Completed
Has Results
  • Adenocarcinoma of the Lung
  • +8 more
  • Winston-Salem, North Carolina
    Wake Forest University Health Sciences
May 30, 2018

Head Neck Cancer Trial in Baltimore (DNA Vaccine, Cyclophosphamide)

Terminated
  • Head and Neck Cancer
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Hospita
Nov 20, 2018

Urothelial Cancer, Bladder Cancer, Adult Trial in Canada (SU011248, Placebo)

Completed
  • Urothelial Cancer
  • +2 more
  • Calgary, Alberta, Canada
  • +4 more
Aug 20, 2018

Solid Tumors Trial in United States (S-3304)

Completed
  • Solid Tumors
  • Denver, Colorado
  • +3 more
Apr 24, 2018

Solid Tumor Trial run by the CC (magnetic resonance imaging, positron emission tomography, fludeoxyglucose F 18)

Completed
  • Unspecified Adult Solid Tumor, Protocol Specific
  • magnetic resonance imaging
  • +2 more
  • Bethesda, Maryland
    Warren Grant Magnuson Clinical Center - NCI Clinical Trials Refe
Sep 23, 2016

NSCLC Stage IV, Chemo Effect Trial in Fuzhou (Thalidomide)

Unknown status
  • NSCLC Stage IV
  • Chemotherapy Effect
  • Fuzhou, Fujian, China
  • +1 more
Nov 12, 2017

Non Small Cell Lung Cancer, Lung Cancer, Stage IIIA Non Small Cell Lung Cancer Trial in United States (S-3304,

Completed
  • Non Small Cell Lung Cancer
  • +3 more
  • La Jolla, California
  • +4 more
Apr 30, 2018

Non-squamous NSCLC Trial (Anlotinib, pemetrexed, Cisplatin)

Unknown status
  • Non-squamous Non-small Cell Lung Cancer
  • (no location specified)
Sep 13, 2018

Nasopharyngeal Carcinoma, Lymphomas, Any EBV+ Solid Tumour Trial in Singapore (LBH589 and RAD001)

Unknown status
  • Nasopharyngeal Carcinoma, Lymphomas, Any EBV+ Solid Tumour
  • LBH589 and RAD001
  • Singapore, Singapore
    National Cancer Center Singapore
Apr 22, 2018

Refractory Multiple Myeloma, Stage I Multiple Myeloma, Stage II Multiple Myeloma Trial in Seattle (clarithromycin, thalidomide,

Completed
  • Refractory Multiple Myeloma
  • +3 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Jun 22, 2017

Multiple Myeloma Trial in Maywood (Bendamustine)

Terminated
Has Results
  • Multiple Myeloma
  • Maywood, Illinois
    Loyola University Medical Center
Jun 15, 2018

Recurrent Thyroid Cancer, Stage IVA Follicular Thyroid Cancer, Stage IVA Papillary Thyroid Cancer Trial in Seattle (sunitinib

Completed
Has Results
  • Recurrent Thyroid Cancer
  • +7 more
  • sunitinib malate
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Mar 13, 2017

Cancer Patients With Solid Tumors Trial in Salt Lake City, Seoul (YN968D1)

Completed
  • Cancer Patients With Solid Tumors
  • Salt Lake City, Utah
  • +1 more
Sep 26, 2017

Epidermolysis Bullosa Simplex, Epidermolysis Bullosa Simplex Kobner, Weber-Cockayne Syndrome Trial in Sydney (Sirolimus 2%,

Unknown status
  • Epidermolysis Bullosa Simplex
  • +2 more
  • Sydney, New South Wales, Australia
    Premier Specialists
Oct 22, 2017

Nasopharyngeal Carcinoma Trial in Guangzhou (Recombinant Human Endostatin Injection (Endostar), Fluorouracil (5-Fu), Nedaplatin)

Unknown status
  • Nasopharyngeal Carcinoma
  • Recombinant Human Endostatin Injection (Endostar)
  • +2 more
  • Guangzhou, Guangdong, China
    Department of Radiation Oncology, Sun Yat-Sen University Cancer
Dec 20, 2017

Gastric Cancer Trial in Beijing (Apatinib)

Unknown status
  • Gastric Cancer
  • Beijing, Beijing, China
    Beijing Friendship Hospital
Aug 31, 2017

Tumors Trial run by the NCI (Fluorine-19-Fluoroded Xyglucose, Topotecan)

Completed
  • Neoplasms
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 30, 2017

Non-small-cell Lung Cancer Trial in Shanghai (Gefitinib, pemetrexed or gemcitabine plus carboplatin,, bevacizumab)

Unknown status
  • Non-small-cell Lung Cancer
  • Shanghai, China
    Department of Oncology, Shanghai pulmonary hospital
Oct 11, 2016